Definitive Contract 75F40125C00105
Award Date
9/30/25
Potential Completion Date
9/29/28
Potential Value
$2.3M
Federal Agency
Food and Drug Administration
Awardee
Florida State University
Ultimate Awardee
Not listed
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tallahassee, FL 32306, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $699,087 firm-fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Duke University, a prestigious private research institution located in Durham, North Carolina. The contract is for basic and applied research and development to support regulatory science and innovation, in alignment with the FDA's mission to protect and promote public health. This award is part of the FDA's agency-wide Broad Agency Announcement (BAA) for research and development. The...
The Food and Drug Administration (FDA) has awarded a $749,661.00 firm fixed-price definitive contract to Duke University, a prestigious private research institution located in Durham, North Carolina. The contract is not set-aside and was issued under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. The BAA solicits basic and applied research and development proposals to support the FDA's mission of protecting and promoting...
This federal contract award, valued at $480,183.00, was made by the Food and Drug Administration (FDA) to Idaho State University to conduct research and development to understand patient information needs and the factors that influence patients' perceived value and trust of healthcare artificial intelligence (AI) applications. The goal is to develop guidance for the FDA and device manufacturers to ensure information is appropriate, transparent, and supports informed decision-making. The contract...
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
The U.S. Food and Drug Administration (FDA) awarded a $515,769.89 firm fixed price definitive contract to the University of St. Gallen, a Swiss educational institution, to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid artificial intelligence to improve risk identification. This contract was awarded under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research...
This is a $500,000 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research for a pharmacokinetic comparison study of locally acting orally inhaled drug products. The contract does not have a set-aside designation, indicating UF competed for and was awarded the contract based on its extensive research capabilities. UF is a major research institution that provides a wide range of goods and services to...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Universitat ST. Gallen, doing business as Hochschule FÜR Wirtschafts-, Rechts- UND Sozialwissenschaften (Hsg), an educational institution. The contract is a Firm Fixed Price definitive contract with a potential value of $764,418.19 and a completion date of September 29, 2023. The contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory...
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
This is a $749,980 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) to develop a "TERATOGENIC RISK IMPACT AND MITIGATION (TRIM): AN EVIDENCE-BASED DECISION FRAMEWORK". The contract has no set-aside designation. UF, through its Division of Sponsored Research, will lead the effort which includes clinical expertise from a subcontractor, The Johns Hopkins University. This contract was awarded under the FDA's Broad Agency...
This is a non-set-aside definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Florida State University (FSU), a U.S. state government and state-controlled institution of higher learning, on January 19, 2023. The $224,962.60 firm fixed price contract is for non-affiliate research services to be performed in Tallahassee, Florida, with a completion date of October 31, 2023. FSU has a history of providing educational services and research...